EXECUTION COPY EXCLUSIVE DISTRIBUTION AND LICENSE AGREEMENT THIS EXCLUSIVE DISTRIBUTION AND LICENSE AGREEMENT is made and entered into as of the 25th day of July 2002 (this "Agreement"), between EPOCH BIOSCIENCES, INC., a Delaware corporation...Exclusive Distribution and License Agreement • November 14th, 2002 • Epoch Biosciences Inc • In vitro & in vivo diagnostic substances • Washington
Contract Type FiledNovember 14th, 2002 Company Industry Jurisdiction
EXCLUSIVE DISTRIBUTION AND LICENSE AGREEMENTExclusive Distribution and License Agreement • April 18th, 2006 • Genesis Bioventures Inc • Services-medical laboratories • Nevada
Contract Type FiledApril 18th, 2006 Company Industry JurisdictionTHIS AGREEMENT, made and entered into this 25th day of January, 2006, by and between Prion Developmental Laboratories, Inc., a Delaware corporation (hereinafter referred to as “PDL”), and Genesis Bioventures, Inc., a New York corporation (hereinafter referred to as "GBI").
EXCLUSIVE DISTRIBUTION AND LICENSE AGREEMENTExclusive Distribution and License Agreement • November 26th, 2014 • Xfit Brands, Inc. • California
Contract Type FiledNovember 26th, 2014 Company JurisdictionThis Exclusive Distribution and License Agreement (“Agreement”) is made effective this 10th day of April 2014 (“Effective Date”) by and between Throwdown Industries Holdings, LLC, a Delaware limited liability company and its affiliates and or assigns (collectively the "Throwdown") and Partner Business Importação e Exportação LTDA, a corporation formed in Brazil ("Licensee"). Corporation and Licensee are individually referred to as “Party” and collectively as the “Parties”.
EXCLUSIVE DISTRIBUTION AND LICENSE AGREEMENT Specialty Allografts and Bone PasteExclusive Distribution and License Agreement • November 15th, 2002 • Regeneration Technologies Inc • Orthopedic, prosthetic & surgical appliances & supplies • Florida
Contract Type FiledNovember 15th, 2002 Company Industry JurisdictionThis Exclusive Distribution and License Agreement (this “Agreement”) is effective as of the 1st day of June, 2002, (the “Effective Date”) by and between Regeneration Technologies, Inc., a Florida corporation (“RTI”), and Medtronic Sofamor Danek USA, Inc., a Tennessee corporation (“MSD”). RTI and MSD are sometimes individually referred to herein as a “Party” and collectively as the “Parties.”